Home Contact
Corporate Governance Partners
About Us
Our Team
Partners
Sequencing Service
Presentations
News Feeds
Cancer Info
Links
LOGIN NAME:

PASSWORD:
Login
Hybrimax

Hybrimax, a San Diego-based joint-venture between Genautica and Multimeric Biotherapeutics is working on developing a method for stimulating B cells in vitro in conjunction with a method for producing monoclonal antibodies such that the process of producing monoclonal antibodies is highly facilitated.